• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用异丙基苯甲酸和香豆霉素基因诱导系统以及纳米孔单细胞克隆技术产生慢病毒载体的包装细胞。

Packaging cells for lentiviral vectors generated using the cumate and coumermycin gene induction systems and nanowell single-cell cloning.

作者信息

Broussau Sophie, Lytvyn Viktoria, Simoneau Mélanie, Guilbault Claire, Leclerc Mélanie, Nazemi-Moghaddam Nazila, Coulombe Nathalie, Elahi Seyyed Mehdy, McComb Scott, Gilbert Rénald

机构信息

Department of Production Platforms & Analytics, Human Health Therapeutics Research Centre, National Research Council Canada, Montreal, QC H4P 2R2, Canada.

Department of Immunology, Human Health Therapeutics Research Centre, National Research Council, Canada, Ottawa, ON K1A 0R6, Canada.

出版信息

Mol Ther Methods Clin Dev. 2023 Feb 26;29:40-57. doi: 10.1016/j.omtm.2023.02.013. eCollection 2023 Jun 8.

DOI:10.1016/j.omtm.2023.02.013
PMID:36936448
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10018046/
Abstract

Lentiviral vectors (LVs) are important for cell therapy because of their capacity to stably modify the genome after integration. This study describes a novel and relatively simple approach to generate packaging cells and producer clones for self-inactivating (SIN) LVs pseudotyped with the vesicular stomatitis virus glycoprotein (VSV-G). A novel gene regulation system, based on the combination of the cumate and coumermycin induction systems, was developed to ensure tight control for the expression of cytotoxic packaging elements. To accelerate clone isolation and ensure monoclonality, the packaging genes were transfected simultaneously into human embryonic kidney cells (293SF-3F6) previously engineered with the induction system, and clones were isolated after limiting dilution into nanowell arrays using a robotic cell picking instrument with scanning capability. The method's effectiveness to isolate colonies derived from single cells was demonstrated using mixed populations of cells labeled with two different fluorescent markers. Because the recipient cell line grew in suspension culture, and all the procedures were performed without serum, the resulting clones were readily adaptable to serum-free suspension culture. The best producer clone produced LVs expressing GFP at a titer of 2.3 × 10 transduction units (TU)/mL in the culture medium under batch mode without concentration.

摘要

慢病毒载体(LVs)因其整合后能稳定修饰基因组的能力,在细胞治疗中具有重要意义。本研究描述了一种新颖且相对简单的方法,用于生成包装细胞和生产克隆,以制备用泡状口炎病毒糖蛋白(VSV-G)假型化的自失活(SIN)慢病毒载体。基于cumate和香豆霉素诱导系统的组合开发了一种新型基因调控系统,以确保对细胞毒性包装元件的表达进行严格控制。为了加速克隆分离并确保单克隆性,将包装基因同时转染到先前用诱导系统工程改造的人胚肾细胞(293SF-3F6)中,并使用具有扫描功能的机器人细胞挑选仪通过有限稀释接种到纳米孔阵列中后分离克隆。使用用两种不同荧光标记物标记的细胞混合群体证明了该方法分离单细胞衍生菌落的有效性。由于受体细胞系在悬浮培养中生长,并且所有操作均在无血清条件下进行,因此得到的克隆易于适应无血清悬浮培养。最佳生产克隆在分批模式下的培养基中无需浓缩即可产生滴度为2.3×10转导单位(TU)/mL的表达绿色荧光蛋白的慢病毒载体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e611/10018046/2a187c3bf465/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e611/10018046/8421e3e89221/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e611/10018046/6e9e134a55bf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e611/10018046/97dcb109bfd8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e611/10018046/7e25174e8589/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e611/10018046/84cd89d916b3/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e611/10018046/f0e6c0657edd/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e611/10018046/664351dfe4c1/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e611/10018046/2a187c3bf465/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e611/10018046/8421e3e89221/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e611/10018046/6e9e134a55bf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e611/10018046/97dcb109bfd8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e611/10018046/7e25174e8589/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e611/10018046/84cd89d916b3/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e611/10018046/f0e6c0657edd/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e611/10018046/664351dfe4c1/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e611/10018046/2a187c3bf465/gr7.jpg

相似文献

1
Packaging cells for lentiviral vectors generated using the cumate and coumermycin gene induction systems and nanowell single-cell cloning.使用异丙基苯甲酸和香豆霉素基因诱导系统以及纳米孔单细胞克隆技术产生慢病毒载体的包装细胞。
Mol Ther Methods Clin Dev. 2023 Feb 26;29:40-57. doi: 10.1016/j.omtm.2023.02.013. eCollection 2023 Jun 8.
2
Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture.用于在无血清悬浮培养中大规模生产慢病毒载体的诱导型包装细胞。
Mol Ther. 2008 Mar;16(3):500-7. doi: 10.1038/sj.mt.6300383. Epub 2008 Jan 8.
3
Generation of stable suspension producer cell lines for serum-free lentivirus production.生产无血清慢病毒的稳定悬浮生产细胞系。
Biotechnol J. 2024 May;19(5):e2400090. doi: 10.1002/biot.202400090.
4
Development of Third-generation Cocal Envelope Producer Cell Lines for Robust Lentiviral Gene Transfer into Hematopoietic Stem Cells and T-cells.用于将慢病毒基因高效转移至造血干细胞和T细胞的第三代共包膜生产细胞系的开发
Mol Ther. 2016 Aug;24(7):1237-46. doi: 10.1038/mt.2016.70. Epub 2016 Apr 8.
5
Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines.利用稳定的HEK293SF生产细胞系进行可扩展的慢病毒载体生产
Hum Gene Ther Methods. 2017 Dec;28(6):330-339. doi: 10.1089/hgtb.2017.086. Epub 2017 Nov 21.
6
Packaging HIV- or FIV-based lentivector expression constructs and transduction of VSV-G pseudotyped viral particles.包装基于HIV或FIV的慢病毒载体表达构建体并转导VSV-G假型化病毒颗粒。
J Vis Exp. 2012 Apr 8(62):e3171. doi: 10.3791/3171.
7
Optimization of production of vesicular stomatitis virus (VSV) in suspension serum-free culture medium at high cell density.在高细胞密度下悬浮无血清培养基中生产水疱性口炎病毒(VSV)的优化。
J Biotechnol. 2019 Jan 10;289:144-149. doi: 10.1016/j.jbiotec.2018.11.023. Epub 2018 Nov 30.
8
Production of lentiviral vectors for transducing cells from the central nervous system.用于转导中枢神经系统细胞的慢病毒载体的生产。
J Vis Exp. 2012 May 24(63):e4031. doi: 10.3791/4031.
9
Development of inducible EIAV-based lentiviral vector packaging and producer cell lines.诱导型 EIAV 基于慢病毒载体包装和生产细胞系的开发。
Gene Ther. 2009 Jun;16(6):805-14. doi: 10.1038/gt.2009.20. Epub 2009 Mar 5.
10
Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.用于长期大规模生产高滴度基于HIV-1的慢病毒载体的包装细胞系的构建
J Gene Med. 2005 Jun;7(6):818-34. doi: 10.1002/jgm.726.

引用本文的文献

1
Enhancing titers of therapeutic lentiviral vectors using PKC agonists.使用蛋白激酶C激动剂提高治疗性慢病毒载体的滴度。
Mol Ther Methods Clin Dev. 2025 May 7;33(2):101484. doi: 10.1016/j.omtm.2025.101484. eCollection 2025 Jun 12.
2
Unveiling molecular secrets: Analysis of stable lentiviral packaging cell lines enables identification of novel viral gene functions.揭开分子秘密:对稳定的慢病毒包装细胞系进行分析有助于鉴定新的病毒基因功能。
Gene Ther. 2025 Apr 15. doi: 10.1038/s41434-025-00533-w.
3
Inducible HEK293 AAV packaging cell lines expressing Rep proteins.

本文引用的文献

1
Culture media selection and feeding strategy for high titer production of a lentiviral vector by stable producer clones cultivated at high cell density.高细胞密度培养的稳定生产克隆生产高滴度慢病毒载体的培养基选择和喂养策略。
Bioprocess Biosyst Eng. 2022 Aug;45(8):1267-1280. doi: 10.1007/s00449-022-02737-5. Epub 2022 Jun 27.
2
High-throughput and automation advances for accelerating single-cell cloning, monoclonality and early phase clone screening steps in mammalian cell line development for biologics production.高通量和自动化技术在提高生物制品生产用哺乳动物细胞系开发中单细胞克隆、单克隆性和早期克隆筛选步骤的速度方面的进展。
Biotechnol Prog. 2021 Nov;37(6):e3208. doi: 10.1002/btpr.3208. Epub 2021 Sep 20.
3
表达Rep蛋白的可诱导型HEK293 AAV包装细胞系。
Mol Ther Methods Clin Dev. 2023 Jul 15;30:259-275. doi: 10.1016/j.omtm.2023.07.002. eCollection 2023 Sep 14.
Lentiviral Vectors for T Cell Engineering: Clinical Applications, Bioprocessing and Future Perspectives.
慢病毒载体在 T 细胞工程中的应用:临床应用、生物工艺学和未来展望。
Viruses. 2021 Aug 2;13(8):1528. doi: 10.3390/v13081528.
4
Novel vectors and approaches for gene therapy in liver diseases.用于肝病基因治疗的新型载体和方法。
JHEP Rep. 2021 Apr 30;3(4):100300. doi: 10.1016/j.jhepr.2021.100300. eCollection 2021 Aug.
5
Lentiviral Vector Bioprocessing.慢病毒载体生物工艺。
Viruses. 2021 Feb 9;13(2):268. doi: 10.3390/v13020268.
6
Update on Clinical Ex Vivo Hematopoietic Stem Cell Gene Therapy for Inherited Monogenic Diseases.遗传性单基因疾病临床体外造血干细胞基因治疗进展。
Mol Ther. 2021 Feb 3;29(2):489-504. doi: 10.1016/j.ymthe.2020.11.020. Epub 2020 Nov 20.
7
Large-Scale Production of Lentiviral Vectors: Current Perspectives and Challenges.慢病毒载体的大规模生产:当前观点与挑战
Pharmaceutics. 2020 Nov 3;12(11):1051. doi: 10.3390/pharmaceutics12111051.
8
Gene and Cell-Based Therapies for Parkinson's Disease: Where Are We?基于基因和细胞的帕金森病疗法:我们在哪里?
Neurotherapeutics. 2020 Oct;17(4):1539-1562. doi: 10.1007/s13311-020-00940-4. Epub 2020 Oct 30.
9
Rapid Lentiviral Vector Producer Cell Line Generation Using a Single DNA Construct.使用单一DNA构建体快速生成慢病毒载体生产细胞系
Mol Ther Methods Clin Dev. 2020 Aug 14;19:47-57. doi: 10.1016/j.omtm.2020.08.011. eCollection 2020 Dec 11.
10
Lentiviral Vector Production from a Stable Packaging Cell Line Using a Packed Bed Bioreactor.使用填充床生物反应器从稳定的包装细胞系生产慢病毒载体。
Mol Ther Methods Clin Dev. 2020 Aug 14;19:1-13. doi: 10.1016/j.omtm.2020.08.010. eCollection 2020 Dec 11.